ADC Therapeutics SA (ADCT)
$1.98 -$0.17 (-7.65%) 4:38 PM 12/12/24
NYSE | $USD | BiotechnologyStock Data
-
Market Cap
$302.64M -
Day's Range
$2.07 - $2.30 -
Volume
1,826,619 -
52 Week Low / High
$0.98 - $6.04 -
PE Ratio
- -
PEG Ratio
- -
Dividend Frequency
-
ADCT's Dividend
Hypothetical 10k Investment Jan 1, 2020
- Capital Growth
- Dividend Return to Date
- Dividend Payout year Est.
- Expenses
- Total Return
- Total Return %
Analyists Ranking
- 4
- Strong Buy
- 2
- Buy
- 1
- Hold
- 0
- Sell
- 0
- Strong Sell
- $8.60
- Target Price
Company News
-
Myricx Bio Announces £90m ($114m) Series A Financing to Advance its Novel NMTi-ADC Therapeutics into Clinical Development — Jul 8th, 2024
Myricx Bio £90m ($114m) series A co-led by new leading life science investors Novo Holdings and Abingworth Additional new investors British Patient Capital, Cancer Research Horizons and Lilly participated alongside founding investors Brandon Capital and Sofinnova Partners Funds will be u...
Similar Stocks
No similar stocks found.
|
Portfolio
$5,000/year
Goal: $10,000/year
Comprised of 1 portfolios
$